| Name | Title | Contact Details |
|---|
Cato Research is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Broadcast Med is a West Hartford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Chambrel At Williamsburg is a Williamsburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NextHealth Technologies (NHT), based in Denver CO, drives measurable medical cost reduction through a prescriptive analytics and consumer engagement platform. NextHealth’s proprietary SaaS platform integrates three foundational technologies - prescriptive analytics, behavioral economics, and multichannel consumer engagement. This end-to end, technology-enabled solution predicts risk reduction opportunities and then prescribes personalized member level actions or “nudges" to dramatically improve outcomes. NHT has been able to deliver a sustained and ground breaking 25% reduction in ER visits and over $17 per member per year in medical claims cost reduction for targeted commercial, ASO, and Medicaid populations. NHT offers over 30+ use cases including ER visit reduction, out-of-network reduction, and retention of high value individual members. NextHealth offers an at risk managed services contract based on 20% of causal claims savings. These results have led the company to be named by Gartner as one of the most innovative healthcare analytics vendors in the US. NHT’s multi-year software and managed services solution is currently contracted and supporting over 1.5 million members with some of the most reputable health plans in the country including: UnitedHealthcare, BlueCross BlueShield of Tennessee, and Colorado Access.
EmpiRx Health is challenging the status quo in today`s pharmacy benefit management industry by offering evidence-based clinical care programs that are aligned with our member`s needs. Our concierge model along with our proactive oversight and agile technology platform provide actionable insight to protect our clients and their members from ever-rising drug costs.